loadpatents
name:-0.011763095855713
name:-0.013844013214111
name:-0.0030450820922852
Antoine; Jean-Christophe Patent Filings

Antoine; Jean-Christophe

Patent Applications and Registrations

Patent applications and USPTO patent grants for Antoine; Jean-Christophe.The latest application filed is for "novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes".

Company Profile
2.8.8
  • Antoine; Jean-Christophe - Saint-etienne FR
  • ANTOINE; Jean-Christophe - Chalain Le Comtal FR
  • Antoine; Jean-Christophe - Chalin Le Comtal FR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
Grant 10,539,577 - Honnorat , et al. Ja
2020-01-21
Novel Human Ulip/crmp Protein And Use Thereof In Diagnosis And Treatment Of Cancers And Paraneoplastic Neurological Syndromes
App 20190119339 - AGUERA; Michele ;   et al.
2019-04-25
Human ULIP/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
Grant 10,087,220 - Aguera , et al. October 2, 2
2018-10-02
Fibroblast Growth Factor Receptors As Diagnostic Markers Of Acquired Sensory Neuronopathies
App 20170343564 - HONNORAT; Jerome Marc Claude ;   et al.
2017-11-30
Fibroblast growth factor receptors as diagnostic markers of acquired sensory neuronopathies
Grant 9,766,253 - Honnorat , et al. September 19, 2
2017-09-19
Fibroblast Growth Factor Receptors As Diagnostic Markers Of Acquired Sensory Neuronopathies
App 20150192594 - Honnorat; Jerome Marc Claude ;   et al.
2015-07-09
Novel Human Ulip/crmp Protein And Use Thereof In Diagnosis And Treatment Of Cancers And Paraneoplastic Neurological Syndromes
App 20130243755 - AGUERA; Michele ;   et al.
2013-09-19
Diagnosis of cancers and paraneoplastic neurological syndromes with novel human ULIP/CRMP protein
Grant 8,377,645 - Aguera , et al. February 19, 2
2013-02-19
Use of a protein of the CRMP family for treating diseases related to the immune system
Grant 7,820,375 - Giraudon , et al. October 26, 2
2010-10-26
Novel human ulip/CRMP protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
App 20080226636 - Aguera; Michele ;   et al.
2008-09-18
Use of a novel human ULIP6/CRMP protein in diagnosis of paraneoplastic neurological syndromes
Grant 7,329,499 - Aguera , et al. February 12, 2
2008-02-12
Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes
App 20070117166 - Aguera; Michele ;   et al.
2007-05-24
Use of ULIP proteins in the diagnosis and therapy of cancers and paraneoplastic neurological syndromes
Grant 7,183,400 - Aguera , et al. February 27, 2
2007-02-27
Use of a protein of the crmp family for treating diseases related to the immune system
App 20050106143 - Giraudon, Pascale ;   et al.
2005-05-19
Novel human ulip/crmp protein and use thereof in diagnosis and treatment of cancers and paraneoplastic neurological syndromes
App 20030176336 - Aguera, Michele ;   et al.
2003-09-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed